GUIDELINES
The body of the abstract is limited to 350 words or less and must represent original work, although previously published work may be used to fulfil this requirement. The total word count for the body of the abstract is 350 words. Titles, authors, and affiliations are excluded from the total word count.
Abstracts can only be submitted via the online abstract submission form. We kindly request you to fill in the necessary information in the form with the following guidelines
The Presenting Author must provide complete contact information (full name, degree, institution, address, telephone number, fax and email address) in the Abstract Submission System.
Category
Select one category from the following list for each abstract submission:
- Acute Myeloid Leukemia
- Acute Lymphoblastic Leukemia
- Cellular Therapy
- Chronic Lymphocytic Leukemia
- Chronic Myeloid Leukemia
- Hodgkin Lymphoma
- Aggressive B-Cell Lymphoma
- Indolent B-Cell Lymphoma
- Mantle Cell Lymphoma
- T-Cell Lymphoma
- Myelodysplastic Neoplasms
- Myeloproliferative Neoplasms
- Multiple Myeloma
Authors may use the following headings (or similar) when preparing the abstract: Context, Objective, Design, Setting, Patients (or Participants), Interven- tions, Main Outcome Measure(s), Results, and Conclusions. Include only those sections that are relevant to your report.
All abstracts should be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication. If you need help, please arrange for the review of your abstract by a colleague who is a native English speaker, by a university specific publications office (or other similar facility) or by a copy editor, prior to submission.
All papers double-blind referee (double blind reviewing) process
IMPORTANT DAYS
Abstract Submission Deadline : March 16, 2025 / 23:59 (Local time)
Congress Dates: May 17-18, 2025